Clinical Trials Logo

Bifurcation Lesion clinical trials

View clinical trials related to Bifurcation Lesion.

Filter by:
  • None
  • Page 1

NCT ID: NCT06166459 Not yet recruiting - Clinical trials for Coronary Artery Disease

Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion

Start date: April 22, 2024
Phase: N/A
Study type: Interventional

Percutaneous coronary intervention for coronary bifurcation lesions represents one of the most challenging procedures in interventional cardiology because of lower angiographic success rate and increased risk of procedural complications. The study is designed to enroll 200 patients with acute or chronic coronary syndromes that meet the indications for intervention and with angiographic confirmed de novo Medina type 0,1,0 or 0,0,1 bifurcation lesion. In view of the potential risks of using DCB alone in the treatment of de novo bifurcation lesions, the following 2 treatment strategies are available. (1) DCB combined with provisional DES implantation 1-2 mm distally to the lesion ostium whenever this was required (DCB+pDES strategy). (2) DES implantation 1-2 mm distally to the lesion ostium followed by DCB (DES+DCB strategy). The primary endpoint was late lumen loss and major adverse cardiovascular events.

NCT ID: NCT03780192 Recruiting - Clinical trials for Coronary Artery Disease

INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique

insProvisional
Start date: February 28, 2019
Phase:
Study type: Observational

Evaluate the efficacy of the Inspiron Sirolimus Eluting Stent on bifurcation coronary artery lesions, in order to preserve and not compromize the side branch using the provisional stent technique.

NCT ID: NCT02972489 Not yet recruiting - Clinical trials for Coronary Artery Disease

Using 3D Imaging to Optimize Bifurcation Stenting

Start date: January 2017
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to determine whether bifurcation stenting guided by on-line three-dimensional optical frequency domain imaging (3D-OFDI) is superior to that with angiographic guidance by measuring incomplete stent apposition (ISA) in the bifurcation segment.